Verkes Borderline Study: The Effect of Quetiapine on Borderline Personality Disordered Patients

Clinical trial NCT00254748 · COMPLETED

Trial details

NCT number: NCT00254748
Sponsor: AstraZeneca
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Borderline Personality Disorder

Start date: 2004-06-01
Enrollment: 40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.